Cytoo

Grenoble, France Founded: 2008 • Age: 18 yrs
Specializes in the development of physiologically-relevant cellular models and assays for High Content Screening

About Cytoo

Cytoo is a Healthcare company based in Grenoble (France) founded in 2008 by Jacques Lewiner. It specializes in the development of physiologically-relevant cellular models and assays for High Content Screening. Cytoo has raised $15.97 million across 3 funding rounds from investors including Sham, Entrepreneurs Fund and Auriga Partners. Its chief executive, as recorded, is Luc Selig. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its legal entity is CYTOO, INC.

Company details

Cytoo was founded in 2008 in Grenoble, France, where physiologically relevant cellular models and assays for high content screening are developed using cell micropatterning. Conventional monolayer cultures are transformed into in-vivo-like phenotypes for reliable assays. Human striated muscle (MyoScreen) and skin (EpiScreen, FibroScreen) models are provided to pharmaceutical, dermato-cosmetic, nutraceutical, food processing, and animal health sectors. Drugs targeting muscle wasting and Duchenne muscular dystrophy are also developed.

  • Headquarters Grenoble, France
  • Founders Jacques Lewiner
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website cytoo.com
  • Social LinkedIn X Facebook YouTube
  • Legal Name Cytoo, Inc.
Key Metrics
  • Total Equity Funding
    $15.97M (USD)

    in 3 rounds

  • Latest Funding Round
    $10M (USD), Series C

    Nov 2011

  • Investors
    Sham

    & 5 more

Apps and channels of Cytoo

its YouTube channel CYTOO has 40 subscribers and 16 videos.

CYTOO
YouTube 40 subscribers 16 videos Science & Technology
Open channel

Videos from Cytoo

The most watched videos on Cytoo's YouTube channel, CYTOO (40 subscribers). Click a video to play it here.

CYTOO CELLebrate
2.1K views
Axon growth cone of primary rat hippocampal neurons on Motility CYTOOchips
2.1K views
Arnaud Chevrollier webinar: mitochondrial networks on micropatterns
1.6K views
Cell proliferation on CYTOOchips Arena 500µm
1.2K views

More on CYTOO.

Funding Insights of Cytoo

Cytoo has successfully raised a total of $15.97M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $10 million completed in November 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $15.97M
  • Total Rounds 3
  • Last Round Series C β€” $10M
  • First Round $1.27M

    (Dec 2008)

  • Investors Count 6

All 3 funding rounds of Cytoo with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2011$10MSeries C–Sham, Entrepreneurs Fund
Sep 2009$4.7MSeries B–Auriga Partners
Dec 2008$1.27MSeed––
Valuation history

6 investors in total: 6 institutional.

Investors in Cytoo

Cytoo has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Sham, Entrepreneurs Fund and Auriga Partners.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Tech & life science focused stage agnostic VC firm investing primarily in Western Europe
entrepreneursfund.comLondon, United Kingdom
Venture capital investments are managed by Auriga Partners in France.
1998aurigapartners.comParis, France
Investments in startups are facilitated to valorize CEA technologies.
1999cea-investissement.comFrance
Kreaxi is engaged in equity financing for innovative startups.
kreaxi.comLimonest, France
expansinvest.fr
Offers insurance, risk management, and training for health and territorial entities.
1927sham.frLyon, France
Premium access

Investor details for Cytoo

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Cytoo

7 people are tracked at Cytoo (5 in leadership, 2 in team).

NameRoleGroup
Jacques Lewiner
Co-FounderLeadership
Luc Selig
CEOLeadership
Alice Gutjahr
Director Of PartnershipsLeadership
Erwann Ventre
Chief Operating OfficerLeadership
Joanne Young
Director R&dLeadership
Bruno Latgé
Business Development ManagerTeam
Nicolas Clément
Ingénieur LogicielTeam
Premium access

Complete people profiles for Cytoo

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Cytoo

3 dated milestones of Cytoo across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Cytoo is founded.
  2. Funding First funding round of $1.3M.
  3. Funding Latest funding round, Series C, of $10.0M.

Web traffic of Cytoo

The website of Cytoo (cytoo.com) receives about 1.6K visits a month.

  • Monthly visits
    1.6K

    ▲ 96.3% vs previous month

Similar websites

Websites whose visitors overlap most with Cytoo. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
inovallee.com
inovallee.com
100%
#2,155,185–
novonordisk.fr
novonordisk.fr
98%
#2,078,176–
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cytoo

Premium access

Complete news archive for Cytoo

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Cytoo

Cytoo was founded in 2008.

Cytoo is headquartered in Grenoble, France. It is registered at Grenoble, Auvergne-rhone-alpes, France.

Luc Selig is the CEO of Cytoo, as recorded in our data.

Cytoo is a funded company, having raised a total of $15.97M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.27M, raised on Dec 2008.

Cytoo was founded in 2008 in Grenoble, France, where physiologically relevant cellular models and assays for high content screening are developed using cell micropatterning. Conventional monolayer cultures are transformed into in-vivo-like phenotypes for reliable assays. Human striated muscle (MyoScreen) and skin (EpiScreen, FibroScreen) models are provided to pharmaceutical, dermato-cosmetic, nutraceutical, food processing, and animal health sectors. Drugs targeting muscle wasting and Duchenne muscular dystrophy are also developed.

Cytoo has 6 investors. Key investors include Sham, Entrepreneurs Fund, Auriga Partners, CEA Investissement, and Kreaxi.

Cytoo operates through Cytoo, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available